<DOC>
	<DOCNO>NCT00910351</DOCNO>
	<brief_summary>Ciprofloxacin PulmoSphere Inhalation Powder appear effective adequate antibiotic treatment cystic fibrosis patient P. aeruginosa colonisation . This plan study first study use new Ciprofloxacin PulmoSphere Inhalation Powder pediatric population 6 12 year age .</brief_summary>
	<brief_title>Cipro Inhaler Cystic Fibrosis Children Ages 6-12</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Male female patient cystic fibrosis confirm genetic testing / sweat test Colonization P. aeruginosa confirm sputum past 12 month Cohort 1 : great equal 18 year age . Cohort 2 : 6 12 year age ( inclusive ) Normal Body Mass Index : BMI 14.5 30 kg/m2 , case lower 30th percentile age . Because CF patient typically small nonCFpatients , normal body mass index base standard CF foundation normal value weight sex . Patients able understand follow instruction able participate study entire period . Patients legal representative must give write informed consent participate study receive adequate previous information prior study specific procedure Patients FEV1 &lt; 35 % predict . FEV1 ( forced expiratory volume ) measure lung function . This exclusion prohibit enrollment patient severely impaired lung function . Patients Burkholderia cepacia colonization respiratory tract Patients acute bronchopulmonary aspergillosis ( ABPA ) Patients lung transplant list Patients acute pulmonary exacerbation Patients severe liver cirrhosis Massive hemoptysis precede 4 week A history relevant diseases vital organ , central nervous system , organ related underlying disease Patients history severe allergy , nonallergic drug reaction , multiple drug allergy Patients hypersensitivity investigational drug quinolones and/ inactive constituent Patients know intolerance hypertonic saline bronchodilator Concomitant inhalation therapy antibiotic / concomitant systemic therapy fluoroquinolones Women pregnant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Inhalation</keyword>
	<keyword>Sputum</keyword>
</DOC>